Intrinsic Value

Karyopharm Therapeutics Inc. (KPTI)

$1.17

-0.11 (-8.59%)

Enterprise Value -23,728.15
Net Debt 124.13
Equity Value -23,852.28
Shares Outstanding 114.22
Equity Value Per Share -208.83



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt